Blogs
Perspective on the forces shaping strategic finance, M&A, and growth in 2026.
Why a Strategic Finance Business Partner Is Crucial for the Growth of Clinical Trial and Biotech Firms in 2026
Great science can open the door to biotech growth. It cannot, by itself, pay clinical sites, fund manufacturing, extend a trial when enrollment slows, or keep a company alive until its next value-creating milestone. That is the tension biotech founders understand better than most – a promising molecule is not the same thing as a […]
Read article →
The 2026 Capital Raising Blueprint: Why Strategic Finance is Your Secret Weapon with Family Offices and VC
In the current fiscal landscape of 2026, the era of "growth at any cost" has been replaced by the "Great Recalibration." For Founders and CEOs, capital is no longer a commodity distributed on potential alone; it is a reward for demonstrated, data-backed resilience. Whether you are knocking on the doors of traditional Venture Capital (VC) […]
Read article →
A Strategic Guide to Canada's Mineral & Critical Mineral Tax Credits
Quick Summary Canada’s mineral exploration tax credit landscape has expanded significantly. The Critical Mineral Exploration Tax Credit (CMETC) provides a 30% non-refundable credit for critical mineral exploration until March 2027, while the traditional Mineral Exploration Tax Credit (METC) offers 15% for grassroots exploration, extended to 2027. Provincial incentives: ranging from 5% to 30%: add additional […]
Read article →
Financial Modeling for Fundraising: Best Practices to Impress Investors
You've built something worth investing in. Your product works, your team is hungry, and your market opportunity is real. But here's the uncomfortable truth: investors see hundreds of pitches every year, and the ones that win aren't always the best businesses: they're the ones with the most compelling, credible financial models. Your financial model isn't […]
Read article →